← Eichor
Study identifier: NCT06522087 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Effect of 40 Hz Transcranial Stimulation on the Incidence of Delirium After Total Hip Replacement or Total Knee Replacement Arthroplasty in Elderly Patients.

Condition: Postoperative Delirium · Anesthesia · Elderly  ·  Sponsor: Henan Provincial People's Hospital

PhaseNA
Planned participants110
Who can joinAll sexes, 65 Years to 85 Years
Healthy volunteersNo

About this study

Delirium is an acute confusional state, it is a sign of acute encephalopathy, also known as acute brain failure, acute brain dysfunction or mental state changes.Postoperative delirium can cause post-traumatic stress disorder, affects patients' quality of life, extend the length of hospital stay, increased hospitalization cost, and is closely relative to short-term and long-term mortality after surgery. Exogenous 40 Hz stimulation can improve cognitive functioning. Therefore, the aim of this study was to investigate the effect of exogenous 40Hz stimulation on the incidence of postoperative delirium in elderly patients undergoing hip and knee replacement.

This description comes directly from the study's public registry record.

Talk to the study team

Zhang jiaqiang  ·  037165580728  ·  hnmzxh@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Henan People's HospitalZhengzhou, Henan, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06522087